Harvard Dermatopathology Update 2024

Welcome and Introduction

Predictive Dermatopathology: Toward more precise assessment of progression risk and therapeutic efficacy in human melanoma
George F. Murphy, MD

Cutaneous T cell lymphoma (CTCL) and mimics
Lyn Duncan, MD

Cutaneous B cell neoplasms
Judith Ferry, MD

Cutaneous Fibrosing Disorders
Rosalynn Nazarian, MD

An Approach to Quality and Safety in Dermatopathology: Quality Improvement and Workflow Redesign
Mia S. DeSimone, MD, MPH

Expert Panel
Lyn Duncan, MD; Mai Hoang, MD; George F. Murphy, MD; Steven Tahan, MD; Julia Lehman, MD

New Insights into Lesions We Thought We Knew
Steven Tahan

Pediatric Dermatopathology
Birgitta Schmidt, MD

New diagnostic criteria for oral leukoplakias
Sook-Bin Woo, DMD

Practical pearls in autoimmune connective tissue diseases
Julia Lehman, MD

Challenging cases of immunobullous diseases
Julia Lehman, MD

Inflammatory Vulvar Lesions
Ashley Ward, MD

HPV-Negative Squamous Vulvar Lesions
Jaclyn Watkins, MD

Updates in Adnexal Neoplasms
Eleanor Russell-Goldman, MD, PhD

Cutaneous Mesenchymal Tumors: Morphology and Molecular Correlates
Ivan Chebib, MD

Pearls and Pitfalls in the diagnosis of cutaneous mycobacterial infections
Alvaro Laga Canales, MD, MSc

Practical approach to difficult melanocytic tumors
Christine G. Lian, MD

Squamous Penile Lesions
Kristine Cornejo, MD

Eye Pathology of Pigmented Lesions
Anna Stagner, MD

ALK+ cutaneous neoplasms
Ruth Foreman, MD, PhD